English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Book Chapter

Setting the stage for universal pharmacological targeting of the glycocalyx

MPS-Authors
/persons/resource/persons293239

Almahayni,  Karim
International Max Planck Research School, Max Planck Institute for the Science of Light, Max Planck Society;
Möckl Research Group, Research Groups, Max Planck Institute for the Science of Light, Max Planck Society;
Friedrich-Alexander Universität Erlangen-Nürnberg;

/persons/resource/persons252559

Möckl,  Leonhard
Möckl Research Group, Research Groups, Max Planck Institute for the Science of Light, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Almahayni, K., & Möckl, L. (2023). Setting the stage for universal pharmacological targeting of the glycocalyx. In The Cardiovascular Glycocalyx in Health and Disease (pp. 61-88). Elsevier.


Cite as: https://hdl.handle.net/21.11116/0000-000D-D919-3
Abstract
All cells in the human body are covered by a complex meshwork of sugars as well as proteins and lipids to which these sugars are attached, collectively termed the glycocalyx. Over the past few decades, the glycocalyx has been implicated in a range of vital cellular processes in health and disease. Therefore, it has attracted considerable interest as a therapeutic target. Considering its omnipresence and its relevance for various areas of cell biology, the glycocalyx should be a versatile platform for therapeutic intervention, however, the full potential of the glycocalyx as therapeutic target is yet to unfold. This might be attributable to the fact that glycocalyx alterations are currently discussed mainly in the context of specific diseases. In this perspective review, we shift the attention away from a disease-centered view of the glycocalyx, focusing on changes in glycocalyx state. Furthermore, we survey important glycocalyx-targeted drugs currently available and finally discuss future steps. We hope that this approach will inspire a unified, holistic view of the glycocalyx in disease, helping to stimulate novel glycocalyx-targeted therapy strategies.